Delivery Order SPE2DE21D7009-SPE2D626F03W3
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $1,834.00 on November 28, 2025, for pain management medical devices and services. The delivery order, which is fixed price with economic price adjustment provisions, has an ultimate completion date of December 5, 2025, and will be performed in Valencia, California. This award represents a child delivery order issued under Boston Scientific Neuromodulation's larger indefinite...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,771.22 for pain management medical devices on November 28, 2025, under a Defense Logistics Agency Troop Support Medical contract. The delivery order, which is fixed-price with economic price adjustment provisions and carries an ultimate completion date of December 5, 2025, represents a task order against the company's larger indefinite delivery contract (SPE2DE)...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $1,867 fixed-price delivery order with economic price adjustment on September 9, 2025, for pain management medical devices. The contract is set to be completed by September 16, 2025, with performance taking place in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a delivery order valued at $2,683.75 for pain management medical devices on November 28, 2025, with an ultimate completion date of December 5, 2025. The contract employs fixed-price pricing with economic price adjustment and is issued without a small business set-aside. The work will be performed in Valencia, California, under the Defense Logistics Agency's Medical Supply Chain procurement entity....
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $2,681.80 on December 19, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of March 2, 2026, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded through the Medical Supply Chain, a defense-related procurement...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $1,867.00 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment authority has an ultimate completion date of February 6, 2026, and will be performed in Valencia, California. The award was made without a set-aside designation by the Medical Supply Chain, a defense-related procurement entity within...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,877.20 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of December 29, 2025, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $1,867.00 fixed-price delivery order with economic price adjustment on November 28, 2025, for pain management medical devices and services. The contract, identified as PAIN MANAGEMENT (4570238376), is set to be completed by December 5, 2025, with performance occurring in Valencia, California. This delivery order was funded by the Medical Supply Chain, a defense-related procurement entity, and represents...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $41,430.34 for pain management medical devices and services. This fixed-price contract with economic price adjustment was awarded on September 9, 2025, with an ultimate completion date of September 19, 2025, and will be performed in Valencia, California. The award carries no set-aside designation, allowing the company to compete openly in the federal marketplace....
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,838.13 for pain management medical devices under a fixed-price contract with economic price adjustment provisions. The award, issued on November 28, 2025, with an ultimate completion date of December 17, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division, a defense-related procurement entity supporting the Department of Defense. The...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F03W3Delivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $5,995.00 fixed-price delivery order (Contract No. 4570238374) by the Defense Logistics Agency's Medical Supply Chain on November 28, 2025, for pain management medical devices and supplies. The delivery order, classified as a child contract with an ultimate completion date of December 5, 2025, represents work to be performed at the contractor's facility in Valencia, California. This award carries no small business set-aside designation and is issued under Boston Scientific Neuromodulation's larger single-award indefinite delivery contract with DLA Troop Support Medical (SPE2DE), valued at approximately $83.1 million and extending through August 2026. Boston Scientific Neuromodulation specializes in advanced neuromodulation therapies for non-opioid pain management, supplying spinal cord stimulation systems, implantable pain pumps, radiofrequency ablation devices, and associated accessories to military treatment facilities and Veterans Affairs medical centers. The company's product portfolio includes proprietary systems such as RestoreSensor and Spectra WaveWriter spinal cord stimulators, along with comprehensive technical support and training services. This delivery order continues the contractor's established role as a critical supplier of pain management technologies to the Defense Health Agency, supporting the military healthcare enterprise's initiatives to provide advanced pain management solutions to service members and veterans recovering from traumatic injuries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 11/27/25 |